InvestorsHub Logo
Followers 95
Posts 11595
Boards Moderated 0
Alias Born 12/27/2011

Re: portfoliomaster post# 3970

Tuesday, 12/12/2017 2:53:10 PM

Tuesday, December 12, 2017 2:53:10 PM

Post# of 9941

company makes no money and there's no avenue for making money for a long, long time and that justifies a quadrupling of market cap?



GW Pharmaceuticals has been losing money for years. Analysts don't expect them to turn a profit until at least 2019 when their leading drug candidate, Epidolex, hits the market. Nevertheless they are trading at $120+/share.

Drug companies are valued for their future potential not their current sales.

That said, we're due for a bit of profit taking and consolidation.

Les

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News